The impact of CFNS-causing EFNB1 mutations on ephrin-B1 function.

Area of Science:

• Genetics and Molecular Biology
• Developmental Biology
• Cell Signaling

Background:

• Mutations in EFNB1 gene cause craniofrontonasal syndrome (CFNS), a complex X-linked disorder.
• CFNS exhibits a unique inheritance pattern, with heterozygous females more severely affected than hemizygous males.
• This sex-dependent severity is attributed to random X-inactivation and cellular interference between wild-type and mutant ephrin-B1 expressing cells.

Purpose of the Study:

• To investigate the functional consequences of patient-derived EFNB1 mutations.
• To analyze mutations predicted to truncate ephrin-B1 or disrupt its signaling pathways.
• To understand the impact of specific EFNB1 mutations on cell behavior and signaling.

Main Methods:

• Analysis of nonsense, frameshift, and splice-site mutations in patient fibroblasts using sequencing, RT-PCR, and Western blot.
• Investigating missense mutations (p.P54L, p.T111I) in NIH 3T3 fibroblasts via site-directed mutagenesis, Western blot, and time-lapse microscopy.
• Assessing cell behavior, Eph-receptor mediated clustering, and intracellular phosphorylation.

Main Results:

• Nonsense (p.R66X) and frameshift (c.614_615delCT) mutations escape nonsense-mediated RNA decay (NMD).
• Splice-site mutation (c.406+2T>C) leads to intron retention or cryptic splice site activation, preventing soluble ephrin-B1 production.
• p.P54L mutation impairs cell clustering and Eph-receptor signaling; p.T111I shows reduced phosphorylation at key sites.

Conclusions:

• Specific EFNB1 mutations lead to truncated proteins or impaired signaling.
• The p.P54L mutation disrupts Eph-ephrin interactions and cell clustering.
• Impaired ephrin-B1 signaling, coupled with cellular interference, underlies CFNS pathogenesis.